If you are taking GLP-1 weight loss medications, you will almost certainly experience fat loss
When the researchers factored in duration of use in secondary analyses, they did detect an increased risk of breast cancer when patients had used GLP-1 analogues for between 2.1 and 3.0 years (hazard ratio [HR] 2.7) and when the time since initiation was between 3.1 and 4.0 years (HR 2.6)
Most participants who experience GI symptoms during the first 20 weeks report minimal or no symptoms by month 12
Even when you lose weight through diet and exercise, certain areas just won't budge
That's not an accident - understanding the regulatory landscape around compounded GLP-1 medications in 2026 matters for making an informed decision, and most marketing materials don't explain it
There is theoretical concern about arginine supplementation following myocardial infarction, as one study suggested potential harm, though this remains controversial